Literature DB >> 25247004

Diabetes in a primary care center among Spaniards and immigrants.

Montserrat Roca Vilalta1, Agueda Castaño Pérez1, Charo López Moya1, Mercedes López Olivares2.   

Abstract

UNLABELLED: Diabetes is a disease with different prevalence in different populations.
OBJECTIVES: The aim of the present study is to describe diabetic patients in a primary care center with regard to their geographic origin, and to determine the status of their disease.
METHODS: A cross-sectional descriptive study, with data available from clinical records in South Tarrasa primary care center (Barcelona, Spain) in 2004.
RESULTS: A total of 1215 diabetic patients with an average age of 65 years, 51% female, were included in the study. Regarding their origin, 97% were from Spain, 2% from Morocco, 0.8% from Latin America, and 0.2% from the rest of Europe. The average Hb1AC was 6.9%. In type 2 diabetic patients, treatment consisted of oral hypoglycemic agents (OHA) for 46.6%, only dietetic restrictions for 36.5%, OHA + insulin for 7.9%, and only insulin for 9%. In the age group 30-39 years, 0.7% of Moroccans suffer from diabetes versus 0.5% of Spaniards. The values in the 40-49 year group are 3.9% of Moroccans, 3% of Spaniards, and 2.1% of Latin Americans. The values in the 50-59 year group are 13.5% of Moroccans, 10.6% of Spaniards, and 7.7% of Latin Americans. The values in the 60-69 year group are 40% of Moroccans, 18.8% of Spaniards, and 44.5% of Latin Americans. The values in the 70-79 year group are 67% of Moroccans, 26% of Spaniards, and 50% of Latin Americans. The average Hb1AC was 6.3% in Latin Americans, 6.9% in Spaniards, and 8.1% in Moroccans. In type 1 diabetic patients, the average Hb1AC was 10.2% in Moroccans and 8% in Spaniards; while in type 2 diabetes, the average Hb1AC was 7.8% in Moroccans and 6.9% in Spaniards. Gestational diabetes was observed in 6.1% of the Spanish, 10.9% of the Moroccan and 4.2% of the Latin American women.
CONCLUSIONS: A higher prevalence of diabetes was detected in Moroccans than in patients from other countries. These patients present poor control of the disease.

Entities:  

Keywords:  Diabetes; Emigration and Immigration; Spain

Year:  2006        PMID: 25247004      PMCID: PMC4166148     

Source DB:  PubMed          Journal:  Pharm Pract (Granada)        ISSN: 1885-642X


INTRODUCTION

In recent years, Europe has received the most important wave of immigrants in the last few centuries. Spain, which was a country of emigrants a few years ago, has become a receiving country. The immigrants who come to find an opportunity to improve their life status chose mainly Catalonia (23%), Madrid (22%), and Andalusia (13%).1,2 The present study was carried out in Tarrasa, close to Barcelona (20 km), a city with a population of almost 200,000 inhabitants that includes 8.26% of foreign inhabitants. Morocco was the main geographical origin (47.8%), followed by Latin America (36.45%; 43% of these were from Ecuador). The Moroccans were mainly males, in contrast to the Latin Americans, who were mainly females (table 1). Moroccan immigrants were young, with only 1.3% older than 65 years, and 78.3% between 16 years and 64 years old.
Table 1

The gender and geographic origin of foreign living in Tarrasa.

MaleFemaleTotal (%)
Morocco493925377476 (47.8)
Rest of Africa545135680 (4.35)
Ecuador113913132452 (15.68)
Rest of Latin America141918293248 (20.77)
Romania10086186 (1.19)
Rest of Europe6215371158 (7.40)
Asia225213438 (2.8)
Total8988665015638
The gender and geographic origin of foreign living in Tarrasa. Many patients find it difficult to understand the concept of a chronic disease that cannot be cured and that requires them to adapt to a new situation, including follow-up and continuous medication, because they associate the disease with some symptoms that prevent them from acting normally. As a consequence, it is difficult to gain compliance with dietetic requirements. This difficulty can be made worse by cultural differences, and may interfere with the treatment of diseases such as diabetes. These differences range from food habits to the perception of the disease, and make it difficult to persuade patients to comply with dietetic and pharmacologic prescriptions, and thus influence their disease control. For example, Moroccans use to consider diabetes to be an occidental disease that would disappear as soon as they returned to Morocco.3,4 This, combined with the fact that the prevalence of diabetes in Morocco is just 1.5–2%, makes it even more difficult to gain compliance.5,6 The aim of the present study is to determine if the prevalence of diabetes mellitus was similar among patients visiting our primary care center, regardless of their geographic origin, and to determine if the control of diabetes was different among groups of different geographic origin.

METHODS

The present study was carried out during 2004 in the primary care center at South Tarrasa, which is an appointed center owned by Mutua de Tarrasa. This health care center assists 21,472 inhabitants, with a high proportion of immigrants. To carry out the study, we reviewed the clinical records of diabetic patients, recording age, gender, geographic origin, type of diabetes, the most recent Hb1AC value, and treatment. The level of diabetes control was categorized following the criteria given by the Servei Català de la Salut (Catalonian Health Service), being: normal a Hb1AC between 4% and 6%; good control, fewer than 7.5%; and poor control, over 7.5%. For immigrant patients, we recorded the year they arrived in Spain. To analyze gestational diabetes, we surveyed all pregnant women cared for in our center during 2004. Data were analyzed with computer program SPSS version 11.5.

RESULTS

The total population of diabetic patients in the primary care center was 1215 people, with an average age of 65 years (SD 14). Ages ranged from 7 years to 99 years. The distribution by gender was quite normal, 598 males (49%) and 617 females (51%). The average ages were 68 years for women and 64 years for men. Glycosylated hemoglobin Hb1AC concentrations ranged from 4% to 12.4%, with an average of 6.9%. We found normal figures in 32% (n = 389), good control in 34.1% (n = 414) and poor control in 28.7% (n = 349). Regarding the type of diabetes, we found that type 1 diabetic patients had poorer control, with Hb1AC = 8%, than type 2 diabetic patients with Hb1AC = 6.9%. All type 1 diabetic patients were treated with insulin. For type 2 diabetic patients, 46.6% (n = 532) were treated with OHA, 36.5% (n = 416) with dietetic restriction only, 7.9% (n = 90) with OHA + insulin, and 9% (n = 103) with insulin. Non-Spanish patients were between 32 years and 76 years old. The prevalence of diabetes for each age group is given in table 2.
Table 2

Prevalence of populations and age groups. diabetes among different

Age (years)Moroccans (%)Spaniards (%)Latin Americans (%)
30-39299 (0.7)3500 (0.5)0
40-49155 (3.9)2671 (3.0)96 (2.1)
50-5937 (13.5)2205 (10.6)26 (7.7)
60-6910 (40.0)1643 (18.8)9 (44.5)
70-793 (67.0)1250 (26)29 (50.0)
Prevalence of populations and age groups. diabetes among different

Diabetes by geographic origin

The Moroccan patients were the youngest diabetic patients (average age 50 years old), followed by Latin Americans (56 years), Spaniards (66 years), and finally the rest of Europe (68 years). Among Spaniards and other Europeans there is no difference between genders (51% females in Spaniards and 50% in other Europeans). On the other hand, 70% of Latin Americans and 46% of Moroccans are women. This is why most of the Morrocan immigrants were males, while Latin American patients were mainly females. The best metabolic control is in the Latin American population, with Hb1AC of 6.3%, followed by Spaniards with Hb1AC of 6.9%, other Europeans with Hb1AC of 7.6%, and finally Moroccans with Hb1AC of 8.1% (table 3).
Table 3

Country of origin, gender and disease control among diabetic patients

Total (%)Age years(SD)GenderHbA1c (%)
Male (%)Female (%)
Spain1117 (97)66 (14)598 (49)617 (51)6.9
Morocco26 (2)50 (14)14 (54)12 (46)8.1
Latin America10 (0.8)56 (14)3 (30)7 (70)6.3
Europe2 (0.2)68 (24)1 (50)1 (50)7.6
Country of origin, gender and disease control among diabetic patients Table 4 presents the distribution of diabetic patients with regard to the time of their diagnosis, and the percentage who came to Spain for family re-grouping
Table 4

Time of diabetes diagnosis and reason for emigration

Age (years)Country of originTime of diagnosisOriginFamily re-grouping
First test in SpainYears after arrivalUnknown
<55-10>10MoroccoLatin America
30-39-11---2--
40-49-2213-622
50-591111-1412
60-6941-111446
70-7931----314
Time of diabetes diagnosis and reason for emigration

Diabetes in Moroccans

The average age in type 1 diabetic Moroccan patients was 33 years, while the average age of the rest of the type 1 diabetic patients was 37 years. Among the type 2 diabetics, on average, Moroccans were 55 years old while the rest were 67 years old. The Hb1AC average in type 1 diabetic Moroccan patients was 10.2%, while the rest of the type 1 diabetics had an Hb1AC average of 8%. In Moroccan type 2 diabetic patients, was 7.8%, while the Hb1AC average for the rest of the type 2 diabetic patients was 6.9%. Of the type 2 diabetic Moroccan patients, 50% were being treated with OHA. Among the rest of the type 2 diabetic patients, half were treated only with dietetic restrictions and the other half were treated with insulin. Among the rest of the type 2 diabetic patients, 46.6% were treated with OHA, 36.5% with dietetic restrictions, 9% with insulin, and 7.9% with OHA + insulin. A total of 372 pregnant women with an average age of 30 years were cared for in the primary care center during 2004 and of these, 24 (6.5%) presented with gestational diabetes: 11% of Moroccan pregnant women, 6% of Spanish and 4.2% of Latin American pregnant women presented with gestational diabetes.

DISCUSSION

We have demonstrated that the initial hypothesis in this study, a greater prevalence of diabetes in Morrocan patients than in Spanish patients, was correct, as seen in figure 1. Previous studies7 found that prevalence of diabetes in the country of origin is much lower than that in the receiving country.
Figure 1

Prevalence of diabetes by age and geographic origin

Probably, one of the reasons for this difference is a change in food habits. In Spain they consume more sweet drinks, more pastry, pre-cooked meals, etc. Among Morrocans, the first immigrant is usually a man, without his family. It is possible that many of them cannot prepare their own meals, and will have an unbalanced intake, including “fast food”. This could help to explain their poorer metabolic control. Another reason for the greater prevalence in the receiving country may be that because on re-aggregating families, a sick family member may take precedence over healthy members. This could explain the enormous prevalence of diabetes in immigrants over 60 years old, who are the parents of those who came to Spain to work. This is confirmed because most of these patients came with a previous diagnosis of diabetes, as seen in table 4. Prevalence of diabetes by age and geographic origin As there is a higher prevalence of diabetes in Moroccans, and their metabolic control is poorer, we consider them to be a group in need of specific education.

CONCLUSIONS

The prevalence of Moroccan diabetic patients in our primary care center is higher than that in Spaniards in all age groups and for all types of diabetes (type 1, type 2 and gestational). The prevalence among Latin-American patients is lower, except in those older than 60 years. Most of our patients present good diabetes control, but that of our Moroccan patients is poor.
  3 in total

1.  [Are there any clinical and metabolic differences between immigrant and Spanish-born diabetic patients?].

Authors:  Guacimara Ortega Sánchez; José Luis Torres Baile; Itziar Salinas Amirola; Mario Cortés Béjar
Journal:  Aten Primaria       Date:  2011-07-21       Impact factor: 1.137

2.  Migrant mortality from diabetes mellitus across Europe: the importance of socio-economic change.

Authors:  Hadewijch Vandenheede; Patrick Deboosere; Irina Stirbu; Charles O Agyemang; Seeromanie Harding; Knud Juel; Snorri Björn Rafnsson; Enrique Regidor; Grégoire Rey; Michael Rosato; Johan P Mackenbach; Anton E Kunst
Journal:  Eur J Epidemiol       Date:  2011-12-14       Impact factor: 8.082

Review 3.  Hispano-Americans in Europe: what do we know about their health status and determinants? A scoping review.

Authors:  Maria Roura; Andreu Domingo; Juan M Leyva-Moral; Robert Pool
Journal:  BMC Public Health       Date:  2015-05-07       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.